New cholesterol-lowering combo shows promise in mid-stage trial

NCT ID NCT07218900

First seen Nov 01, 2025 · Last updated May 06, 2026 · Updated 25 times

Summary

This study tests whether adding a new drug (AZD0780) to a standard statin (rosuvastatin) can lower bad cholesterol more than the statin alone. About 76 adults with dyslipidaemia in Russia will take either the combination or a placebo plus statin for 12 weeks. The goal is to see if the new drug helps more people reach healthy cholesterol levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSLIPIDAEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Aramil, 624002, Russia

  • Research Site

    RECRUITING

    Ivanovo, 153012, Russia

  • Research Site

    RECRUITING

    Moscow, 105554, Russia

  • Research Site

    RECRUITING

    Moscow, 111539, Russia

  • Research Site

    RECRUITING

    Moscow, 117292, Russia

  • Research Site

    RECRUITING

    Moscow, 121552, Russia

  • Research Site

    RECRUITING

    Perm, 614000, Russia

  • Research Site

    RECRUITING

    Saint Petersburg, 194156, Russia

  • Research Site

    SUSPENDED

    Saratov, 410054, Russia

Conditions

Explore the condition pages connected to this study.